PGProcter & Gamble

$151.25-1.8% 1Y

Is the price fair?

Fair

Neither cheap nor expensive: growth expectations in line with delivery and in its normal P/E range.

2 neutral, 1 without data
What the price assumes~+8% a year

Priced for ~8% a year FCF growth. Moderate growth expectations are priced in.

Vs its own P/E rangemid-range for this companyderived

In its normal range: P/E 22.9 vs a 22.3 median over 41 quarters (+3% vs median).

Vs sector (EV/EBIT)19.0×

Sector median 16.6× across 78 covered peers. EV/EBIT counts debt as part of the price, so a cash-rich and a borrowed company can be compared on the same footing.

Unless marked, from derived, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

P/E (valuation)middle of the market
FCF yieldmiddle of the market

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

What PG's price assumes

Procter & Gamble trades at 22.9× earnings against 23.6× for the median Household & Personal Products name, cheaper than its own group.

22.9

Trailing P/E · Household & Personal Products median 23.6 · cheaper than the typical name in its group

Price / sales
4.02

Price / sales · today's price, trailing year to Jun 30, 2026

Free cash flow yield
4.3%

Free cash flow yield · Household & Personal Products median 7.2%

Growth the price implies
+7.6%

Growth the price implies · The price pays for +7.6% free cash flow growth a year for a decade; the business has delivered +3.2% a year over the last three.

Details›
Price / booktoday's price, trailing year to Jun 30, 2026
6.45
EV / EBITtoday's price, trailing year to Jun 30, 2026
19.0
EV / salestoday's price, trailing year to Jun 30, 2026
4.30
Consumer Defensive median P/E142 names
20.2
Household & Personal Products median P/E18 names
23.6
Free cash flow, trailing twelve months
$15.1B
Market capitalisation
$350.2B
3-year revenue growth
+2.0%
3-year free cash flow growth
+3.2%
What the market has paid for these earnings: 41 quarters of its own multiple × $6.62 of trailing earnings per share
MethodPer share
Its own P/E history, lower quartile$129.68
Its own P/E history, median$147.42
Its own P/E history, upper quartile$160.54
52-week range$136.04 – $165.95
Today$151.25

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.